Emerging mechanisms of immunosuppression in oral cancers

A Jewett1, C Head, N A Cacalano

  • 1The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, Jonsson Comprehensive Cancer Center (JCCC), Department of Head and Neck Surgery, UCLA School of Dentistry and Medicine 90095-1688, USA. ajewett@ucla.edu

Journal of Dental Research
|November 24, 2006
PubMed

Insights

Oral cancers suppress anti-tumor immunity via tumor cell mechanisms. This review explores how transcription factors like NF-kappaB and STAT3 contribute to immune suppression in the oral tumor microenvironment.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Effective anti-tumor immune responses are crucial for tumor clearance.
  • Oral cancers often evade immune surveillance through complex mechanisms.
  • Impaired function of immune cells like NK cells, T-cells, and dendritic cells is observed in oral cancer patients.

Purpose of the Study:

  • To review emerging mechanisms of immune suppression in oral cancers.
  • To highlight the role of tumor cell-derived factors in modulating the immune microenvironment.
  • To focus on the impact of key transcription factors on immune evasion.

Main Methods:

  • Literature review of existing studies on oral cancer immunology.
  • Analysis of proposed mechanisms of immune suppression.
  • Focus on signaling pathways and transcription factors involved in immune evasion.

Main Results:

  • Tumor cells actively suppress anti-tumor immune responses.
  • Soluble factors and cell-contact mediated mechanisms contribute to immune suppression.
  • Elevated NF-kappaB and STAT3 transcription factors play a significant role in mediating immune suppression within the tumor microenvironment.

Conclusions:

  • Understanding these immunosuppressive mechanisms is vital for developing effective oral cancer therapies.
  • Targeting transcription factors like NF-kappaB and STAT3 may offer novel therapeutic strategies.
  • Further research into the oral tumor microenvironment's immune interactions is warranted.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...